Boston & New England CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
Life Sciences Veteran Greg Lewis Joins Cresa in Boston
Greg Lewis has joined the Boston office of Cresa as a principal. With more than 20 years’ experience in facilities planning and operations, Greg will lead business development efforts within the life sciences market and manage ongoing occupancy.
Before joining Cresa, Greg was a project executive and head of the life sciences team at J. Calnan & Associates. Previously, he was a VP and national life sciences sector head at STV | DPM.
On the client side, he has held leadership positions in real estate planning and management at Shire Pharmaceuticals (now Takeda), Wyeth Pharmaceuticals (now Pfizer), and Millennium Pharmaceuticals (now Takeda).
“Greg’s industry experience as a service partner and perhaps more importantly as an end user himself, will be invaluable for further delivering value to our life sciences, biotech, and medical technology clients,” said Adam Subber, managing principal of Cresa’s Boston office.
For comments, questions or concerns, please contact Paul Bubny
- ◦People
